May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?
- PMID: 32405159
- PMCID: PMC7217767
- DOI: 10.1016/j.numecd.2020.05.003
May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?
Conflict of interest statement
Declaration of Competing Interest The authors have no conflicts of interest to disclose.
References
-
- Glende J., Schwegmann-Wessels C., Al-Falah M., Pfefferle S., Qu X., Deng H. Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2. Virology. 2008;381:215–221. doi: 10.1016/j.virol.2008.08.026. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
